Phase I Study of EOS789
Phase 1
- Conditions
- Healthy volunteer
- Registration Number
- JPRN-jRCT2080222940
- Lead Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 112
Inclusion Criteria
Japanese or Caucasian healthy male volunteers aged 20 to 44 years
Body mass index (BMI) between 18.5 and 25.0 kg/m^2 for Japanese subjects and 18.5 and 30.0 kg/m^2 for Caucasian subjects at the time of screening
Exclusion Criteria
Evidence of any cardiovascular, renal, hepatic, gastrointestinal, hematologic, immunologic, nervous, endocrine, metabolic, pulmonary disorders or history of these disorders with renal, hepatic, cardiac function disorder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety, tolerability and pharmacokinetics<br>Observation/examination
- Secondary Outcome Measures
Name Time Method Pharmacodynamics<br>Examination